Viewing Study NCT04400058


Ignite Creation Date: 2025-12-25 @ 12:22 AM
Ignite Modification Date: 2026-02-20 @ 1:03 AM
Study NCT ID: NCT04400058
Status: COMPLETED
Last Update Posted: 2024-01-18
First Post: 2020-05-21
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression
Sponsor: Octapharma
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: GAM10-10
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators